Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy [3]

Journal of Acquired Immune Deficiency Syndromes

Volumn 27, Issue 3, 2001, Pages 318-320

  Bijl, Micon ^a   Dieleman, Jeanne P ^a   Simoons, Maarten ^a   Van Der Ende, Marchina E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ANGINA PECTORIS; CARDIOTOXICITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0035394318     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200107010-00018     Document Type: Letter

References (6)

1. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients
2. Cardiovascular involvement during HIV infection
3. Frequency and factors associated with cardiomyopathy in patients with human immunodeficiency virus infection in an inner city hospital
4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
5. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: Advantages of a new specific activity scale
6. Echocardiographic measurements in normal subjects: Evaluation of an adult population without clinically apparent heart disease